Serveur d'exploration Covid (26 mars) - Analysis (an2020)

Index « AbsEn.i » - entrée « host »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
hospitals < host < hosted  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 28.
[0-20] [0 - 20][0 - 28][20-27][20-40]
Ident.Authors (with country if any)Title
000133 (2020) [An update on the epidemiological characteristics of novel coronavirus pneumonia(COVID-19)].
000199 (2020) Xian Peng ; Xin Xu ; Yuqing Li ; Lei Cheng ; Xuedong Zhou ; Biao RenTransmission routes of 2019-nCoV and controls in dental practice
000240 (2020) Yan-Rong Guo ; Qing-Dong Cao ; Zhong-Si Hong ; Yuan-Yang Tan ; Shou-Deng Chen ; Hong-Jun Jin ; Kai-Sen Tan [Singapour] ; De-Yun Wang [Singapour] ; Yan YanThe origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status
000317 (2020) Swatantra Kumar [Inde] ; Vimal K. Maurya [Inde] ; Anil K. Prasad [Inde] ; Madan L B. Bhatt [Inde] ; Shailendra K. Saxena [Inde]Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV).
000327 (2020) Junwen Luan [République populaire de Chine] ; Yue Lu [République populaire de Chine] ; Xiaolu Jin [République populaire de Chine] ; Leiliang Zhang [République populaire de Chine]Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection.
000330 (2020) Daniel Batlle [États-Unis] ; Jan Wysocki [États-Unis] ; Karla Satchell [États-Unis]Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?
000373 (2020) Markus Hoffmann [Allemagne] ; Hannah Kleine-Weber [Allemagne] ; Simon Schroeder [Allemagne] ; Nadine Krüger [Allemagne] ; Tanja Herrler [Allemagne] ; Sandra Erichsen [Autriche] ; Tobias S. Schiergens [Allemagne] ; Georg Herrler [Allemagne] ; Nai-Huei Wu [Allemagne] ; Andreas Nitsche [Allemagne] ; Marcel A. Müller [Russie] ; Christian Drosten [Allemagne] ; Stefan Pöhlmann [Allemagne]SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
000376 (2020) Joseph Thomas Ortega [États-Unis] ; Maria Luisa Serrano [Venezuela] ; Flor Helene Pujol [Venezuela] ; Hector Rafael Rangel [Venezuela]Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An in silico analysis
000409 (2020) Yushun Wan [États-Unis] ; Jian Shang [États-Unis] ; Rachel Graham [États-Unis] ; Ralph S. Baric [États-Unis] ; Fang Li [États-Unis]Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus.
000559 (2020) Yadi Zhou [États-Unis] ; Yuan Hou [États-Unis] ; Jiayu Shen [États-Unis] ; Yin Huang [États-Unis] ; William Martin [États-Unis] ; Feixiong Cheng [États-Unis]Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
000564 (2020) Mirko Baglivo [Italie] ; Manuela Baronio [Italie] ; Giuseppe Natalini [Italie] ; Tommaso Beccari [Italie] ; Pietro Chiurazzi [Italie] ; Ezio Fulcheri [Italie] ; Paolo Pietro Petralia [Italie] ; Sandro Michelini [Italie] ; Giovanni Fiorentini [Italie] ; Giacinto Abele Miggiano [Italie] ; Assunta Morresi [Italie] ; Gerolamo Tonini [Italie] ; Matteo Bertelli [Italie]Natural small molecules as inhibitors of coronavirus lipid-dependent attachment to host cells: a possible strategy for reducing SARS-COV-2 infectivity?
000605 (2020) Li Runfeng [République populaire de Chine] ; Hou Yunlong [République populaire de Chine] ; Huang Jicheng [République populaire de Chine] ; Pan Weiqi [République populaire de Chine] ; Ma Qinhai [République populaire de Chine] ; Shi Yongxia [République populaire de Chine] ; Li Chufang [République populaire de Chine] ; Zhao Jin [République populaire de Chine] ; Jia Zhenhua [République populaire de Chine] ; Jiang Haiming [République populaire de Chine] ; Zheng Kui [République populaire de Chine] ; Huang Shuxiang [République populaire de Chine] ; Dai Jun [République populaire de Chine] ; Li Xiaobo [République populaire de Chine] ; Hou Xiaotao [République populaire de Chine] ; Wang Lin [République populaire de Chine] ; Zhong Nanshan [République populaire de Chine] ; Yang Zifeng [République populaire de Chine]Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2).
000615 (2020) Jared S. Morse [États-Unis] ; Tyler Lalonde [États-Unis] ; Shiqing Xu [États-Unis] ; Wenshe Ray Liu [États-Unis]Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV.
000670 (2020) Eakachai Prompetchara [Thaïlande] ; Chutitorn Ketloy [Thaïlande] ; Tanapat Palaga [Thaïlande]Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic.
000697 (2020) Yu Shi ; Xia Yu ; Hong Zhao ; Hao Wang ; Ruihong Zhao ; Jifang ShengHost susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan
000704 (2020) Hao Xu ; Liang Zhong ; Jiaxin Deng ; Jiakuan Peng ; Hongxia Dan ; Xin Zeng ; Taiwen Li ; Qianming ChenHigh expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa
000727 (2020) Chun Li [République populaire de Chine] ; Yanling Yang [République populaire de Chine] ; Linzhu Ren [République populaire de Chine]Genetic evolution analysis of 2019 novel coronavirus and coronavirus from other species.
000766 (2020) Xingguang Li [République populaire de Chine] ; Junjie Zai [République populaire de Chine] ; Qiang Zhao [République populaire de Chine] ; Qing Nie [République populaire de Chine] ; Yi Li [République populaire de Chine] ; Brian T. Foley [États-Unis] ; Antoine Chaillon [États-Unis]Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2.
000770 (2020) Abdul Mannan Baig [Pakistan] ; Areeba Khaleeq [Pakistan] ; Usman Ali [Pakistan] ; Hira Syeda [Pakistan]Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms.
000798 (2020) Naveen Vankadari [Australie] ; Jacqueline A. Wilce [Australie]Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26.
000936 (2020) Lorenzo D'Antiga [Italie]Coronaviruses and immunosuppressed patients. The facts during the third epidemic.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/an2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/an2020/Analysis/AbsEn.i -k "host" 
HfdIndexSelect -h $EXPLOR_AREA/Data/an2020/Analysis/AbsEn.i  \
                -Sk "host" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/an2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV2
   |flux=    an2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    host
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021